XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.21.1

Benefit Plans | 6 Months Ended
--- | ---
Apr. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Benefit Plans | Note 17. Benefit Plans We have stockholder approved equity incentive plans, a stockholder approved Employee Stock Purchase Plan and an employee tax-deferred savings plan. During the six months ended April 30, 2021, the Company approved a sub-plan to its 2018 Omnibus Incentive Plan, as amended and restated, which is described in more detail below. 2018 Omnibus Incentive Plan The Company’s 2018 Omnibus Incentive Plan (as amended and restated from time to time, the “2018 Incentive Plan”) authorizes grants of stock options, stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance shares, performance units and incentive awards to employees, directors, consultants and advisors. Stock options, RSAs and SARs have restrictions as to transferability. Stock option exercise prices are fixed by the Company’s Board of Directors but shall not be less than the fair market value of our common stock on the date of the grant. SARs may be granted in conjunction with stock options. On November 24, 2020, the Company’s Board of Directors approved a Long Term Incentive Plan (the “LTI Plan”) as a sub-plan consisting of awards made under the 2018 Incentive Plan. The participants in the LTI Plan are members of senior management and include the Company’s named executive officers (as identified in the definitive proxy statement filed by the Company on February 19, 2021). The LTI Plan consists of three award components: (1) relative total shareholder return (“TSR”) performance units, (2) absolute TSR performance units, and (3) time-vesting restricted stock units. The performance units granted during the three months ended January 31, 2021 will be earned over the performance period ending on October 31, 2023, but will remain subject to a continued service-based vesting requirement until the third anniversary of the date of grant. The performance measure for the relative TSR performance units is the TSR of the Company relative to the TSR of the Russell 2000 from November 1, 2020 through October 31, 2023. The performance measure for the absolute TSR performance units is an increase in the Company’s stock price during the performance period of November 1, 2020 through October 31, 2023. The time-vesting RSUs granted during the three months ended January 31, 2021 will vest at a rate of one-third of the total number of RSUs on each of the first three anniversaries of the date of grant. None of the awards granted as part of the LTI Plan include any dividend equivalent or other stockholder rights. To the extent the awards are earned, they may be settled in shares or cash of an equivalent value at the Company’s option. On November 24, 2020, 848,078 RSUs were awarded under the LTI Plan, which include 551,252 performance units and 296,826 time-based units. Should the Company’s share price achieve the 200% performance level, awardees will receive up to 551,252 additional RSUs. The performance units were valued based on a Monte-Carlo Simulation, and the estimated fair value of the 275,626 relative TSR performance units are $14.41 per share and the estimated fair value of the 275,626 absolute TSR performance units are $15.36 per share. The performance units and time-based units will be expensed over the three-year service period. On April 8, 2021, the Company’s stockholders approved an amendment and restatement of the 2018 Incentive Plan to authorize the Company to issue up to 8,000,000 additional shares of the Company’s common stock. Following the approval of the amendment and restatement, the Company has the authority to issue a total of 12,333,333 shares of the Company’s common stock. Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | Three months Ended April 30, | ​ | Six months Ended April 30,
​ |  | ​ | 2021 |  | ​ | 2020 | ​ | 2021 |  | 2020
Cost of revenues | ​ | $ | 141 | ​ | $ | 105 | ​ | $ | 318 | ​ | $ | 222
General and administrative expense | ​ | ​ | 1,054 | ​ | ​ | 242 | ​ | ​ | 2,237 | ​ | ​ | 581
Research and development expense | ​ | ​ | 31 | ​ | ​ | 14 | ​ | ​ | 63 | ​ | ​ | 35
​ | ​ | $ | 1,226 | ​ | $ | 361 | ​ | $ | 2,618 | ​ | $ | 838
​ Restricted Stock Awards and Restricted Stock Units Including Performance Based Awards The following table summarizes our RSA and RSU activity for the six months ended April 30, 2021:
​ | ​ | ​ | ​ | ​ | ​ | ​
Restricted Stock Awards and Units |  | ​ | Shares |  | Weighted-Average Fair Value
Outstanding as of October 31, 2020 | ​ | ​ | 2,067,140 | ​ | $ | 5.06
Granted - performance units | ​ | ​ | 551,252 | ​ | ​ | 14.89
Granted - time-vesting restricted stock units | ​ | ​ | 296,826 | ​ | ​ | 3.28
Vested | ​ | ​ | (221) | ​ | ​ | 20.40
Outstanding as of January 31, 2021 | ​ | ​ | 2,914,997 | ​ | $ | 5.46
Granted - time-vesting restricted stock units | ​ | ​ | 37,550 | ​ | ​ | 11.05
Vested | ​ | ​ | (81,878) | ​ | ​ | 13.13
Forfeited | ​ | ​ | (53,532) | ​ | ​ | 10.86
Outstanding as of April 30, 2021 | ​ | ​ | 2,817,137 | ​ | $ | 5.24
​

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration